ACRIVON THERAPEUTICS INC (ACRV)

US0048901096 - Common Stock

8.89  +0.33 (+3.86%)

After market: 8.89 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.00
Operating Expenses
67.10M32.66M16.18M3.17M
Research and Development
46.02M23.95M13.72M1.87M
Selling, General, and Administrative Expenses
21.08M8.71M2.47M1.30M
Operating Income
-67.10M-32.66M-16.18M-3.17M
Interest Income/Expense
N/AN/A0.00-2.10M
Other Income/Expense
6.71M1.49M-160.00K-40.00K
Non Recurring Items
N/AN/A100.00KN/A
Income Before Taxes
-60.39M-31.17M-16.24M-5.31M
Net Income
-60.39M-31.17M-16.24M-5.31M
EBITDA
-66.57M-32.30M-16.14M-3.16M
 
Per Share Data
EPS Diluted Total Ops
-2.74-1.42-0.78-0.25
Non GAAP EPS
-2.73N/AN/AN/A
 
Statistics

All data in USD

Charts